Anti-Obesity Drug Discovery and Development

Anti-Obesity Drug Discovery and Development

Volume: 3

Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric ...
[view complete introduction]

US $
30

*(Excluding Mailing and Handling)



Unravelling Potential Anorexigen Effects of Nesfatin-1: How Homeostatic Mechanisms Help Balance Excess Calories

Pp. 65-79 (15)

Carmine Finelli

Abstract

In this chapter, we review the current concepts about Nesfatin-1 as a new anti-obesity treatment and evaluate the existing issues about this knowledge and the available literature. The intent is to inform clinicians about Nesfatin-1 as a new kind of anti-obesity treatment and make a rational decision based on this perspective as possible clinical application. It can be potentially helpful in the therapy of metabolic disorders and obesity of various origins. In fact, the details of nesfatin-1 physiology could be clarified, and it may be considered suitable in the future as a potential drug in the pharmacotherapy of obesity, due to its anorexigenic effects, and as a new potential modulator of appetite in the therapy of eating disorders such as anorexia nervosa by using selective nesfatin-1 antagonists. Therefore, further progress of pharmacological researches in this field is still very limited. Further research on this topic certainly merit attention.

Keywords:

Drug treatment, Eating disorders, Feeding behaviour, Nesfatin-1, Obesity.

Affiliation:

Department of Emergency and Internal Medicine, S. Maria della Pietà Nola’s Hospital, Via della Repubblica 1, 80035 Nola (Na), Italy.